Stockreport

Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Sensei Biotherapeutics, Inc.  (SNSE) 
PDF - Full data for Phase 1/2 dose expansion cohort expected by year-end 2025 - - Cash runway into the second quarter of 2026 - BOSTON, Aug. 05, 2025 [Read more]